United Kingdom

Harrison, H., Ip, S., Renzi, C., Li, Y., Barclay, M., Usher-Smith, J., et al. (2024). Implementation and external validation of the Cambridge Multimorbidity Score in the UK Biobank cohort. Bmc Med Res Methodol, 24, 71. http://doi.org/10.1186/s12874-024-02175-9
Lee, C., Rizzi, S., Bierrenbach, A. L., Antunes, L., Nissinen, N. M., Rocha, O., et al. (2024). Identification of misclassified pregnancy episodes in women of childbearing potential exposed to drugs with known teratogenic potential in the CPRD GOLD Pregnancy Register. Pharmacoepidemiol Drug Saf, 33, e5761. http://doi.org/10.1002/pds.5761
Druce, K. L., Yimer, B. B., Humphreys, J., Njuki, L. N., Bourke, D., Li, M., et al. (2023). The epidemiology of psoriatic arthritis in the UK: a health intelligence analysis of UK Primary Care Electronic Health Records 1991-2020. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/kead586
Tsang, C., Huda, A., Norman, M., Dickerson, C., Leo, V., Brownrigg, J., et al. (2023). Detecting transthyretin amyloid cardiomyopathy (ATTR-CM) using machine learning: an evaluation of the performance of an algorithm in a UK setting. Bmj Open, 13, e070028. http://doi.org/10.1136/bmjopen-2022-070028
Rees, J., de Almeida, M., Ali, M., Covernton, P. J. O., Stoelzel, M., Leyland, K. M., et al. (2023). A Retrospective Database Analysis to Investigate Treatment Patterns and Health Care Resource Utilisation in Patients who CYCLe AntiMuscarinics in ENgland (CYCLAMEN). Eur Urol Focus. http://doi.org/10.1016/j.euf.2023.09.017
Zaccardi, F., Byrne, K., Khunti, K., Kloecker, D., Reynoso, R., Shabnam, S., et al. (2023). The impact of COVID-19 lockdowns on the body mass index of people living with obesity: A UK retrospective cohort study using the UK Clinical Practice Research Datalink. Obes Res Clin Pract. http://doi.org/10.1016/j.orcp.2023.09.008
Heward, E., Dempsey, J., Lunn, J., Molloy, J., Isba, R., Carr, M., et al. (2023). Protocol for the Paediatric Otorrhoea Study (POSt): a multi-methods study to understand the burden of paediatric otorrhoea in the UK. Bmj Open, 13, e078052. http://doi.org/10.1136/bmjopen-2023-078052
Little, D. J., Arnold, M., Hedman, K., Sun, P., Haque, S. A., & James, G. (2023). Rates of adverse clinical events in patients with chronic kidney disease: analysis of electronic health records from the UK clinical practice research datalink linked to hospital data. Bmc Nephrol, 24, 91. http://doi.org/10.1186/s12882-023-03119-z
Eworuke, E., Shinde, M., Hou, L., Paterson, M. J., Jensen, P. B., Maro, J. C., et al. (2023). Valsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study. Bmj Open, 13, e070985. http://doi.org/10.1136/bmjopen-2022-070985
Carey, I. M., Nirmalananthan, N., Harris, T., DeWilde, S., Chaudhry, U. A. R., Limb, E., & Cook, D. G. (2023). Prevalence of co-morbidity and history of recent infection in patients with neuromuscular disease: A cross-sectional analysis of United Kingdom primary care data. Plos One, 18, e0282513. http://doi.org/10.1371/journal.pone.0282513